Catherine M. Szyman - May 7, 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: May 7, 2024
Transactions value $: -$51,820
Form type: 4
Date filed: 5/9/2024, 07:36 PM
Previous filing: May 6, 2024
Next filing: May 13, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Award	$0	+32K	+70.27%	$0.00	77.6K	May 7, 2024	Direct	F1
transaction	EW	Common Stock	Tax liability	-$51.8K	-609	-0.78%	$85.09	77K	May 7, 2024	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units were granted on May 7, 2024 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person.